The U.S. remains critically dependent on China for rare earth processing and pharmaceutical precursors, posing a significant geopolitical and supply chain risk.
Nvidia's long-term growth story beyond its current hyperscaler dominance faces investor skepticism.
The massive consumer use of unregulated AI like ChatGPT for healthcare advice risks widespread medical misinformation.
SpaceX is currently losing billions of dollars on its AI initiatives despite its massive long-term market projections.
Opportunities Identified
The 'agentic era' of AI presents a multi-trillion dollar market opportunity for companies that can develop autonomous software agents.
Government-backed onshoring of critical supply chains, particularly in mid-stream processing for rare earths, offers a major investment area.
Increased institutional and retail allocation to infrastructure, especially in the energy sector, is being driven by global reindustrialization.
Clinically-validated AI healthcare platforms can address primary care shortages and significantly reduce employer healthcare spending.